Literature DB >> 22221788

Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.

Dana Shanis1, Melissa Merideth, Tajana Klepac Pulanic, Bipin N Savani, Minoo Battiwalla, Pamela Stratton.   

Abstract

Female long-term survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) incur a significant burden of late effects. Genital graft-versus-host disease (GVHD), human papillomavirus (HPV) reactivation, ovarian failure and infertility, sexual dysfunction, and osteoporosis are concerns that can significantly impact quality of life. This review examines the risk, pathogenesis, clinical presentation, and implications of these common complications. Recommendations are provided for evaluation and management of these late effects and other obstetric and gynecologic issues that may arise in this patient population. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22221788      PMCID: PMC3257831          DOI: 10.1053/j.seminhematol.2011.10.002

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  79 in total

1.  Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.

Authors:  Smita Bhatia; Liton Francisco; Andrea Carter; Can-Lan Sun; K Scott Baker; James G Gurney; Philip B McGlave; Auayporn Nademanee; Margaret O'Donnell; Norma K C Ramsay; Leslie L Robison; David Snyder; Anthony Stein; Stephen J Forman; Daniel J Weisdorf
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

2.  Ovarian recovery after stem cell transplantation.

Authors:  J Liu; R Malhotra; J Voltarelli; A B Stracieri; L Oliveira; B P Simoes; E D Ball; E Carrier
Journal:  Bone Marrow Transplant       Date:  2007-10-22       Impact factor: 5.483

Review 3.  Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility.

Authors:  Leslie R Schover
Journal:  J Clin Oncol       Date:  2008-02-10       Impact factor: 44.544

4.  Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.

Authors:  Karen L Syrjala; Brenda F Kurland; Janet R Abrams; Jean E Sanders; Julia R Heiman
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

5.  Labial fusion: a rare complication of chronic graft-versus-host disease.

Authors:  John M Norian; Pamela Stratton
Journal:  Obstet Gynecol       Date:  2008-08       Impact factor: 7.661

6.  Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation.

Authors:  Pamela Stratton; Maria L Turner; Richard Childs; John Barrett; Michael Bishop; Alan S Wayne; Steven Pavletic
Journal:  Obstet Gynecol       Date:  2007-11       Impact factor: 7.661

Review 7.  Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer.

Authors:  M Hickey; C Saunders; A Partridge; N Santoro; H Joffe; V Stearns
Journal:  Ann Oncol       Date:  2008-06-02       Impact factor: 32.976

Review 8.  Vaccination after stem cell transplant: a review of recent developments and implications for current practice.

Authors:  Marissa B Wilck; Lindsey R Baden
Journal:  Curr Opin Infect Dis       Date:  2008-08       Impact factor: 4.915

Review 9.  Endocrinological late complications after hematopoietic SCT in children.

Authors:  A Cohen; A N Békássy; A Gaiero; M Faraci; S Zecca; A Tichelli; G Dini
Journal:  Bone Marrow Transplant       Date:  2008-06       Impact factor: 5.483

10.  Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination.

Authors:  Bipin N Savani; Pamela Stratton; Aarthi Shenoy; Eleftheria Kozanas; Stacey Goodman; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

View more
  19 in total

1.  Gynecologic care after hematopoietic cell transplantation: a call to action to include gynecologists in the transplant team.

Authors:  P Stratton
Journal:  Bone Marrow Transplant       Date:  2014-11-03       Impact factor: 5.483

2.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Authors:  Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

Review 3.  Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.

Authors:  Minoo Battiwalla; André Tichelli; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2016-11-03       Impact factor: 5.742

4.  Acute pain crisis in a patient with sickle cell disease undergoing ovarian simulation for fertility preservation prior to curative stem cell transplantation: case report and literature review.

Authors:  Michelle Matthews; Rebecca Pollack
Journal:  J Assist Reprod Genet       Date:  2017-08-11       Impact factor: 3.412

Review 5.  Clinical management of genital chronic GvHD.

Authors:  B K Hamilton; O Goje; B N Savani; N S Majhail; P Stratton
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483

6.  Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD.

Authors:  B Frey Tirri; P Häusermann; H Bertz; H Greinix; A Lawitschka; C-P Schwarze; D Wolff; J P Halter; D Dörfler; R Moffat
Journal:  Bone Marrow Transplant       Date:  2014-10-27       Impact factor: 5.483

7.  Chronic Myeloid Leukaemia: A paradigm for malignancy or just a strange disease?

Authors:  Shaun R McCann
Journal:  Sultan Qaboos Univ Med J       Date:  2012-11-20

Review 8.  Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis.

Authors:  Brigitte Gerstl; Elizabeth Sullivan; Jana Koch; Handan Wand; Angela Ives; Richard Mitchell; Nada Hamad; Antoinette Anazodo
Journal:  Support Care Cancer       Date:  2019-09-21       Impact factor: 3.603

9.  Human papillomavirus reactivation following treatment of genital graft-versus-host disease.

Authors:  T Sri; M A Merideth; T Klepac Pulanic; R Childs; P Stratton
Journal:  Transpl Infect Dis       Date:  2013-05-28       Impact factor: 2.228

10.  A Rare Consequence of Chronic Graft Versus Host Disease - Peyronie's Disease.

Authors:  Natasha A Jain; Krishnan Venkatesan; Prathima Anandi; Sawa Ito; Dhruv Kumar; Kit Lu; Minoo Battiwalla; A John Barrett
Journal:  Arch Cancer Res       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.